A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it? | STAT News
A cholesterol-cutting drug from Amgen succeeded in lowering patients' risk of cardiovascular trouble in a huge clinical trial — but the results, announced Friday, may not be good enough to prompt insurers to cover the expensive drug for millions of patients.
Texas Braces For Medicaid Cuts Under GOP Health Plan | NPR
Many in Texas are keeping a close eye on the Republican bid to replace the Affordable Care Act. One of the big changes is how it would affect low-income people, seniors, and people with disabilities who get help from Medicaid. And people on both sides of the political spectrum say the Lone Star State is not going to fare well.
Why Improving Population Health Makes Financial Sense | Forbes
When you think that only 10% of health outcomes, according to the Bipartisan Policy Center, are a result of the clinical care a person receives, you start thinking differently about what is needed to improve population health.
Health Care Management on the Rise for MBA Students | U.S. News & World Report
Opportunities in health care management go beyond the traditional job description of managing a hospital or clinic, says June Kinney, associate director of the graduate program in Health Care Management at Wharton. "Graduates find jobs in digital health, insurance, finance, pharmabiotech, venture capital, medical devices and entrepreneurship," she notes.
